Jaiyare, Jaysa H.
HRN: 14-31-84 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/31/2022
CEFUROXIME 1.5GM (VIAL)
08/31/2022
09/07/2022
IVT
1.5g
On Call To OR Then Q8
For Completion Curettage
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Guideline Not Available
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes